Syvolap VV, Vizir-Tronova OV. Influence of additional risk factors on the antihypertensive efficacy of eprosartan and telmisartan in patients with essential hypertension. Pathologia [Internet]. 2017Dec.22 [cited 2024Aug.1];(3). Available from: http://pat.zsmu.edu.ua/article/view/118311